Lastly, to assess the therapeutic potential of targeting the SLC15A4-TASL complex in autoimmune diseases, we investigated its relevance in a chemically-induced SLE model initiated by pristane (2,6,10,14-tetramethylpentadecane, TMDP) injection. This evidence concerns the gene SLC15A4 and autoimmune disease.